By Brady Granier, President & CEO, Director, BioCorRx Inc
The intended purpose of MAT for opioid use disorder includes a decrease in illicit opioid use, decreased mortality, and improved long-term sobriety.
By Slava Akmaev, SVP, Chief Analytics Officer, Co-founder & Head of Berg Analytics, BERG Health
A handful of companies have been using AI methodologies in target discovery by analyzing vast amounts of data.
By Dr. Dhrumil Shah, CMIO/CIO, Compass Medical
Healthcare is in a major flux right now and a cloud of uncertainty looms above, keeping our vision obscured.
By Rajeev Nair, VP & CIO, Jubilant Pharma
Homogenizing and integrating the various key processes for each newly acquired entity, without compromising on the differentiation that each of them needs to strengthen their competitive advantage is a key element of the growth strategy.
By Ashok Upadhyay, IT Sr. Director, Otsuka Pharmaceutical Development & Commercialization, Inc. (U.S.)
In the world of omnipresent social media and smart user-centric devices, digital technologies continue to redefine newer and better ways for people to interact with one another.
By Christopher Ferrara, Senior Director, Industry Solutions, Qlik
In this fast paced and cost-conscious industry, few Life Sciences companies have the appetite to spend millions of dollars or wait for months to access something that is all around us–data.
By Paul Blake, Associate Director, GEP Worldwide
To re-imagine what is possible, without the limits that the status-quo imposes, and to work out how best to use our intellect and creativity